Formulation for inhalation
US5980949A · kind A · utility
17Cited by
23References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 9, 1998 |
| Grant date | Nov 9, 1999 |
| Priority date | — |
| Expiry date | Jan 9, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/58
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A dry powder composition comprising terbutaline sulphate and a carrier substance, both of which are in finely divided form, wherein the formulation has a poured bulk density of from 0.28 to 0.38 g/ml is useful in the treatment of respiratory disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.